Theradiag
Business Services · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
14 Rue Ambroise Croizat Cs 2, Croissy-Be...Phone Number
+33 164621012Website
www.theradiag.comRevenue
$13.9 MillionStock Symbol
ALTERIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Theradiag
Theradiag specializes in biotherapy monitoring and in vitro diagnostics, providing innovative solutions to enhance patient treatment management. With over 30 years of experience, the company offers a range of CE-marked kits, including the LISA TRACKER, for monitoring biotherapy treatments and diagnosing autoimmune diseases. Its product portfolio also includes solutions for male fertility issues and infectious disease diagnostics. Theradiag aims to continuously expand its offerings to improve biotherapy monitoring across various therapeutic areas.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Theradiag your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Theradiag
Theradiag, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Theradiag is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Theradiag has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Theradiag has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Theradiag recently announced quarterly report
Click to see if Theradiag had a recent Job posting/layoffs
Product Launch: Get notified when Theradiag launches new products
Recommended Actions
Reach out to Masked Content who joined Theradiag as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Theradiag is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Theradiag is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Theradiag.
Theradiag Tech Stack
A closer look at the technologies used by Theradiag
Theradiag News & Media
Theradiag: Appointment of an Independent Expert
CROISSY-BEAUBOURG, France--(BUSINESS WIRE)--Regulatory News: THERADIAG (ISIN: FR0004197747, Ticker: ALTER) (Paris:ALTER), a company specializing in in vitro diagnostics and Theranostics, announces the appointment of Crowe HAF by the Company's Board of Directors as independent expert within the framework of the proposed voluntary public tender offer filed by Biosynex. On September 23, 2022, Biosynex filed with the Autorité des marchés financiers (the "AMF") a proposed voluntary cash tender offerTheradiag Announces Its Results for the First Half of 2022: Breaking-Even and Confirming Its Ability to Be Structurally Profitable From Early 2023
CROISSY-BEAUBOURG, France--(BUSINESS WIRE)--Regulatory News: THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and Theranostics, today announces its half-year results to June 30, 2022, as approved by the Board of Directors on September 15, 2022. 2022 half-year results In thousands of euros H1 2022 H1 2021 % change Revenue 6,264 5,482 +14% of which: Theranostics 3,024 2,766 +9 % of which: IVDQuotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics
JERSEY, Channel Islands, June 08, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced an agreement with Theradiag, a market leader in autoimmune disease testing and pioneer in theranostics, under which the two companies will partner to advance autoimmune diagnostics by leveraging Quotient’s MosaiQ platform.Theradiag: Report of the Ordinary and Extraordinary General Meeting of 5 May 2022
CROISSY-BEAUBOURG, France--(BUSINESS WIRE)--Regulatory News: THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, announces that the ordinary and extraordinary general meeting held today was able to validly deliberate, as the quorum was reached. The shareholders of the Company adopted all the resolutions of the ordinary and extraordinary general meeting, except for resolutions nb. 5, 7, 8, 9 and 21. In particular, the ordinary general m
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Theradiag
Sign Up For FreeTo access detailed company insights
Theradiag specializes in biotherapy monitoring and in vitro diagnostics, providing innovative solutions to enhance patient treatment management. With over 30 years of experience, the company offers a range of CE-marked kits, including the LISA TRACKER, for monitoring biotherapy treatments and diagnosing autoimmune diseases. Its product portfolio al... Read More
